MoonLake Immunotherapeutics dismisses Withum and engages Baker Tilly as auditor post-merger

MoonLake Immunotherapeutics

Audit Committee dismissed WithumSmith+Brown as independent auditor effective June 15, 2022.
Baker Tilly US, LLP was engaged as the new independent registered public accounting firm on the same date.
Withum's prior reports contained a going-concern paragraph related to the SPAC's pre-merger status; no disagreements or reportable events occurred.
The business combination with MoonLake AG closed on April 5, 2022, resolving the going-concern uncertainty.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.